3/4
08:00 am
elut
Elutia Regains Compliance with Nasdaq Listing Requirements
Low
Report
Elutia Regains Compliance with Nasdaq Listing Requirements
3/2
08:00 am
elut
Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market
Medium
Report
Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market
2/25
04:05 pm
elut
Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026
Medium
Report
Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026
2/18
08:00 am
elut
Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™
Low
Report
Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™
1/12
08:00 am
elut
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones
Medium
Report
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones
1/9
08:13 am
elut
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery [Yahoo! Finance]
Medium
Report
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery [Yahoo! Finance]
1/9
08:00 am
elut
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery
Medium
Report
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery